Chevy Chase GHK-Cu Peptide Therapy US$ 25.97 Min. order: 1 piece ★★★★★ 4.7 (270 reviews) Sold : Login>>
ADA 2025: CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials US$ 27.61 Min. order: 1 piece ★★★★★ 4.0 (184 reviews) Sold : Login>>
CagriSema for Type 2 Diabetes · Info for Participants · Phase Phase 3 Clinical Trial 2026 | Power US$ 24.06 Min. order: 1 piece ★★★★★ 4.4 (60 reviews) Sold : Login>>
CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 21.78 Min. order: 1 piece ★★★★★ 4.0 (204 reviews) Sold : Login>>